Trial Profile
Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth?
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Feb 2017
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Abdominal pain; Bacterial infections
- Focus Therapeutic Use
- 01 Jul 2009 Actual number of patients (115) added as reported by ClinicalTrials.gov
- 01 Jul 2009 Actual end date (1 Sep 2008) added as reported by ClinicalTrials.gov
- 01 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov